Krystal Biotech, Inc. is a commercial-stage biotechnology company focused on the discovery, development, and commercialization of genetic medicines to treat diseases with high unmet medical needs. Its first commercial product, VYJUVEK, is approved in the United States, European Union, and Japan for the treatment of dystrophic epidermolysis bullosa.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.